Abstract

BackgroundHaematological malignancies (leukaemias, lymphomas and myeloma) are complex cancers that are relatively common, affect all ages and have divergent outcomes. Although the symptom burden of these diseases is comparable to other cancers, patients do not access specialist palliative care (SPC) services as often as those with other cancers. To determine the reasons for this, we asked SPC practitioners about their perspectives regarding the barriers and facilitators influencing haematology patient referrals.MethodsWe conducted a qualitative study, set within the United Kingdom’s (UK’s) Haematological Malignancy Research Network (HMRN: www.hmrn.org), a population-based cohort in the North of England. In-depth, semi-structured interviews were conducted with 20 SPC doctors and nurses working in hospital, community and hospice settings between 2012 and 2014. Interviews were digitally audio-recorded, transcribed and analysed for thematic content using the ‘Framework’ method.ResultsStudy participants identified a range of barriers and facilitators influencing the referral of patients with haematological malignancies to SPC services. Barriers included: the characteristics and pathways of haematological malignancies; the close patient/haematology team relationship; lack of role clarity; late end of life discussions and SPC referrals; policy issues; and organisational issues. The main facilitators identified were: establishment of inter-disciplinary working patterns (co-working) and enhanced understanding of roles; timely discussions with patients and early SPC referral; access to information platforms able to support information sharing; and use of indicators to ‘flag’ patients’ needs for SPC. Collaboration between haematology and SPC was perceived as beneficial and desirable, and was said to be increasing over time.ConclusionsThis is the first UK study to explore SPC practitioners’ perceptions concerning haematology patient referrals. Numerous factors were found to influence the likelihood of referral, some of which related to the organisation and delivery of SPC services, so were amenable to change, and others relating to the complex and unique characteristics and pathways of haematological cancers. Further research is needed to assess the extent to which palliative care is provided by haematology doctors and nurses and other generalists and ways in which clinical uncertainty could be used as a trigger, rather than a barrier, to referral.

Highlights

  • Haematological malignancies are complex cancers that are relatively common, affect all ages and have divergent outcomes

  • Characteristics and pathways of haematological malignancies (Table 2) Interviewees said that the most significant barrier to haematology patients accessing specialist palliative care (SPC) services was the unpredictable trajectories and prognoses associated with the diseases

  • One commonly cited example of this was the propensity for unexpected deterioration and rapid death, often when patients were being treated with intensive chemotherapy, which resulted in insufficient time to instigate an SPC referral

Read more

Summary

Introduction

Haematological malignancies (leukaemias, lymphomas and myeloma) are complex cancers that are relatively common, affect all ages and have divergent outcomes. Haematological malignancies (leukaemias, lymphomas and myeloma) are generally considered a complex group of diseases that account for around one in ten of all cancers and affect all ages [1]. Patients with haematological cancers typically experience symptoms as a consequence of both their disease and/or the side effects of treatment. These manifest physically and psychologically, and are comparable in number, severity and distress to those experienced by patients with other cancers [4,5,6,7]. The importance of good symptom control and end of life care is widely recognised, there is some evidence of unmet needs in settings outside of the United Kingdom (UK) [6, 8, 9]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call